Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Randomized Experiments01:13

Randomized Experiments

7.1K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
7.1K
Clinical Trials: Overview01:11

Clinical Trials: Overview

3.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.1K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

229
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
229
Clinical Trials01:16

Clinical Trials

6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.9K
Neural Regulation01:37

Neural Regulation

39.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.6K
Blinding01:11

Blinding

2.5K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factors associated with psychological distress among end-of-life care volunteers: a systematic review of quantitative and qualitative evidence.

BMC palliative care·2026
Same author

Optimizing intravenous solid tumour treatment through active targeting approaches and polymeric micelles engineering: A meta-analysis in mouse models.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Subthalamic segmentations in relation to deep brain stimulation volumes in Parkinson's disease.

Acta neurochirurgica·2026
Same author

Place of death in Parkinson's disease: A systematic review and meta-analysis of associated factors.

Journal of Parkinson's disease·2026
Same author

Frequency-specific and spatiotemporal dynamics of β-γ phase-amplitude coupling in Parkinson's disease.

Brain : a journal of neurology·2026
Same author

Patients with symmetric Parkinson's disease do poorly with subthalamic stimulation.

Journal of neurology, neurosurgery, and psychiatry·2026

Related Experiment Video

Updated: Jul 30, 2025

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
08:53

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke

Published on: June 6, 2025

418

Randomizing a clinical trial in neuro-degenerative disease.

Anthony C Atkinson1, Belmiro P M Duarte2,3, David J Pedrosa4,5

  • 1Department of Statistics, London School of Economics, London WC2A 2AE, United Kingdom.

Contemporary Clinical Trials Communications
|May 14, 2023
PubMed
Summary

This study evaluates randomization rules for Parkinson's disease clinical trials using patient data. It recommends specific allocation rules for different trial sites to minimize bias and imbalance.

Keywords:
BiasBiased-coin designEmpirical multivariate distributionLossMinimizationRandomization

More Related Videos

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

258
Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability
08:22

Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability

Published on: October 7, 2017

8.2K

Related Experiment Videos

Last Updated: Jul 30, 2025

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
08:53

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke

Published on: June 6, 2025

418
Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

258
Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability
08:22

Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability

Published on: October 7, 2017

8.2K

Area of Science:

  • Clinical Trials
  • Biostatistics
  • Neurology

Background:

  • Parkinson's disease clinical trials require robust randomization methods.
  • Existing methods may not fully account for patient covariate distributions.
  • A sample of 144 Parkinson's patients provided response and prognostic factor data.

Purpose of the Study:

  • To evaluate and compare different randomization rules for a sequential, two-treatment, two-site clinical trial.
  • To develop a simulation model using empirical patient data for trial analysis.
  • To recommend optimal allocation rules for Parkinson's disease trials.

Main Methods:

  • Utilized a sample of 144 Parkinson's patients for covariate distribution modeling.
  • Employed a two-stage algorithm for simulating covariate distributions.
  • Performed simulations to compare six different allocation rules based on imbalance and bias.
  • Generated empirical marginal distributions from a correlated multivariate normal distribution.

Main Results:

  • Quantified the loss due to imbalance and potential bias for each allocation rule.
  • Identified specific randomization rules that perform better under simulated conditions.
  • Demonstrated the utility of using empirical patient data in simulation models.

Conclusions:

  • The study recommends two distinct allocation rules, one for each trial site.
  • Recommendations are contingent upon the target number of patients to be enrolled.
  • The findings offer practical guidance for designing Parkinson's disease clinical trials.